Literature DB >> 11416701

Emergency room management of hypertensive urgencies and emergencies.

D G Vidt1.   

Abstract

Hypertensive crisis affects upward of 500,000 Americans each year. Although the incidence of hypertensive crisis is low, affecting fewer than 1% of hypertensive adults, more than 50 million adult Americans suffer from hypertension. Presentation of a patient with severe hypertension to the emergency room demands immediate evaluation, prompt recognition of a hypertensive emergency or urgency, and the prompt institution of appropriate therapeutic measures to prevent progression of target-organ damage and to avoid a catastrophic event. Hypertensive emergencies are severe elevations in blood pressure that are complicated by evidence of progressive target-organ dysfunction such as coronary ischemia, disordered cerebral function, a cerebrovascular event, pulmonary edema, or renal failure. Although therapy with parenteral antihypertensive agents may be initiated in the emergency department, these patients warrant prompt admission to an intensive care unit where continuous monitoring of blood pressure can be assured during therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11416701      PMCID: PMC8101895          DOI: 10.1111/j.1524-6175.2001.00449.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  16 in total

1.  Acute management of severe hypertension with oral labetalol.

Authors:  R R Ghose
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  How urgent is 'urgent' hypertension?

Authors:  R K Ferguson; P H Vlasses
Journal:  Arch Intern Med       Date:  1989-02

3.  Labetalol infusion in hypertensive emergencies.

Authors:  M Lebel; S Langlois; L J Belleau; J H Grose
Journal:  Clin Pharmacol Ther       Date:  1985-06       Impact factor: 6.875

Review 4.  Current management of hypertensive emergencies.

Authors:  J Y Garcia; D G Vidt
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 5.  Hypertension in the emergency department.

Authors:  R E Jackson
Journal:  Emerg Med Clin North Am       Date:  1988-05       Impact factor: 2.264

6.  Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group.

Authors: 
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

7.  Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group.

Authors:  E A Panacek; E M Bednarczyk; L M Dunbar; G E Foulke; T L Holcslaw
Journal:  Acad Emerg Med       Date:  1995-11       Impact factor: 3.451

8.  Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.

Authors:  M A Munger; W F Rutherford; L Anderson; A I Hakki; F M Gonzalez; E M Bednarczyk; G Emmanuel; S G Weed; E A Panacek; J A Green
Journal:  Crit Care Med       Date:  1990-05       Impact factor: 7.598

9.  Hypertensive crisis treated with orally administered captopril.

Authors:  J Biollaz; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery.

Authors:  J T Flaherty; P A Magee; T L Gardner; A Potter; N P MacAllister
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  10 in total

1.  Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified.

Authors:  Patrick Campbell; William L Baker; Stephen D Bendel; William B White
Journal:  J Am Soc Hypertens       Date:  2011-09-03

Review 2.  The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All?

Authors:  Ana-Maria Balahura; Ștefan-Ionuț Moroi; Alexandru Scafa-Udrişte; Emma Weiss; Cristina Japie; Daniela Bartoş; Elisabeta Bădilă
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Treatment of hypertensive urgencies and emergencies.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

Review 4.  Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room.

Authors:  Alessandro Maloberti; Giulio Cassano; Nicolò Capsoni; Silvia Gheda; Gloria Magni; Giulia Maria Azin; Massimo Zacchino; Adriano Rossi; Carlo Campanella; Andrea Luigi Roberto Beretta; Andrea Bellone; Cristina Giannattasio
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-05-18

Review 5.  Hypertensive crises: emergencies and urgencies.

Authors:  Donald G Vidt
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

6.  Hypertensive urgency.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

7.  Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013.

Authors:  Alexander T Janke; Candace D McNaughton; Aaron M Brody; Robert D Welch; Phillip D Levy
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

8.  Evaluation of the clinical outcome of captopril use for hypertensive urgency in Khartoum State's emergency centres.

Authors:  Amgad H H Obied; Aimun A E Ahmed
Journal:  Afr J Emerg Med       Date:  2020-11-19

9.  Patients with hypertensive crises who are admitted to a coronary care unit: clinical characteristics and outcomes.

Authors:  Héctor González Pacheco; Neisser Morales Victorino; Juan Pablo Núñez Urquiza; Alfredo Altamirano Castillo; Ursulo Juárez Herrera; Alexandra Arias Mendoza; Francisco Azar Manzur; Jose Luis Briseño de la Cruz; Carlos Martínez Sánchez
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-01-09       Impact factor: 3.738

Review 10.  Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.

Authors:  Utkarsh Ojha; Sanjay Ruddaraju; Navukkarasu Sabapathy; Varun Ravindran; Pitchaya Worapongsatitaya; Jeesanul Haq; Raihan Mohammed; Vinod Patel
Journal:  Am J Cardiovasc Drugs       Date:  2021-12-08       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.